NAMS Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-25144/A0001968582-26-000878SEC →
2026-08-2540001193125-26-365202SEC →
2026-08-241440001968582-26-000868SEC →
2026-08-148-K/A0001193125-26-352233SEC →
2026-08-1430001193125-26-352209SEC →
2026-08-148-K0001193125-26-352186SEC →
2026-08-06SCHEDULE 13G/A0000315066-26-002082SEC →
2026-08-058-K0001193125-26-333827SEC →
2026-08-0510-Q0001193125-26-333824SEC →
2026-07-248-K0001193125-26-315163SEC →
2026-07-228-K0001193125-26-312390SEC →
2026-07-2240001193125-26-312387SEC →
2026-06-2440001193125-26-281062SEC →
2026-06-05S-80001193125-26-259794SEC →
2026-06-04SCHEDULE 13G/A0001422849-26-000108SEC →
2026-06-038-K0001193125-26-254615SEC →
2026-05-2740001193125-26-241983SEC →
2026-05-261440001968582-26-000491SEC →
2026-05-14SCHEDULE 13D/A0001193125-26-224656SEC →
2026-05-078-K0001193125-26-210283SEC →
2026-05-0710-Q0001193125-26-210272SEC →
2026-05-06ARS0001193125-26-207564SEC →
2026-05-06DEF 14A0001193125-26-207562SEC →
2026-05-06SCHEDULE 13G/A0000315066-26-001273SEC →
2026-04-248-K0001193125-26-177406SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
NewAmsterdam Pharma Company N.V. (NAMS) — Filings